◆ What the Market Isn't Pricing In

Berkshire Hathaway (BRK.B) — the variant view

Priced at 1.44 times book like a fading monument, built as a fortress with $365 billion of cash — an option on the next panic.

📈 BRK.B valuation, revenue & earnings — P/E, P/S, revenue, EPS →

Berkshire trades at 1.44 times its book value and about $1.08 trillion1 in market value, and the fashionable verdict on it is that of a magnificent machine now running out of road — too big to grow quickly, sitting on a mountain of idle cash, and having just lost the one man who made it special. There is truth in that picture, and I have laid out its dangers at length. But the market, in pricing Berkshire as a slowing giant, may be underweighting a few things less obvious than the headline worries.

Net earnings against operating earnings ($B)$96.2BNet 2023$37.4BOper. 2023$89.0BNet 2024$47.4BOper. 2024$67.0BNet 2025$44.5BOper. 2025Operating = net earnings less investment gains and impairments; Forms 10-K
GAAP profit swings by tens of billions with stock prices; operating earnings move slowly.

The first is what the cash actually is. About $365 billion in cash and Treasury bills at the end of June 202623 is, on the surface, a drag — money earning a modest yield while everyone waits. But it is also the largest pool of deployable, unencumbered capital in corporate history, held by the one buyer temperamentally built to use it when everyone else is paralyzed. In a genuine crisis — the kind that arrives every decade or so — that hoard is not dead weight but a loaded spring, capable of buying wonderful assets at panic prices while forced sellers dump them. The market prices the cash at its yield; its real value is the optionality of having it precisely when it is scarcest.

The second is the quality of what Berkshire already owns. Underneath the holding-company wrapper sits a collection of genuinely good businesses — a great railroad, a vast regulated utility, the finest insurance operation in the world, a portfolio of blue-chip equities — most of them deeply moated and richly cash-generative. Valued as a sprawling conglomerate, the whole tends to be marked below the sum of its parts; valued as what it is, a curated set of durable earning power plus a war chest, it may be worth rather more than 1.44 times book suggests. And the reported figures understate it: GAAP earnings swing wildly with the mark-to-market of the stock portfolio4, so the placid, growing stream of operating earnings — $44.5 billion in 20255 — is the truer measure, obscured by accounting noise the market half-remembers to look through.

The third, and most contested, is the transition itself. The consensus fear is that Berkshire without Buffett is merely a large, well-run holding company. That may prove right. But it is at least possible the market is over-discounting a handover planned for decades, executed cleanly, and inherited by an enterprise deliberately engineered to run without heroics. Greg Abel took the reins with the balance sheet at its strongest, resumed the buybacks Buffett had paused — $4.8 billion in the first half of 2026 —6 and signaled unbroken discipline. If the institution performs even competently, the founder's premium the market is busy withdrawing may prove to have been withdrawn too soon.

None of this is a prediction, and the bearish case is honest and strong: size genuinely caps returns, the cash genuinely earns too little while it waits, and the loss of a singular capital allocator is a real subtraction no structure fully replaces. The spectacular decades are almost certainly behind it. But the gap worth noticing is between a market pricing Berkshire as a fading monument and a business that is, on the evidence, a fortress-strong compounder with unmatched dry powder, above-average assets, and a transition that may go better than the fear implies. The thing the market may not be paying for is the simple, unglamorous possibility that Berkshire remains exactly what it was built to be: durable, disciplined, and quietly worth more than a nervous consensus assumes.

References
  1. Third-party estimateBerkshire trades at 1.44 times its book value and about $1.08 trillion in market value, and the fashionable verdict on it is that of a magnificent machine now running out of road — too big to grow quickly, sitting on a mountain of idle cash, and having just lost the one man who made it special.
    Stock market data, September 2026 - Berkshire market capitalization $1.08T, price-to-book 1.44, price-to-earnings 12.57, price-to-sales 2.80 — September 2026 · publ. 2026-09-23 · source ↗
  2. ReportedAbout $365 billion in cash and Treasury bills at the end of June 2026 is, on the surface, a drag — money earning a modest yield while everyone waits.
    Berkshire Hathaway Form 10-Q, quarter ended 30 June 2026 - after-tax earnings (underwriting $1,731M vs $1,992M, insurance investment income $3,059M vs $3,367M, BNSF $1,558M vs $1,466M, BHE $891M vs $702M, manufacturing, service and retailing $4,470M vs $3,601M, investment gains $12,684M, net earnings $25,667M); GEICO pre-tax underwriting $994M vs $1,821M, combined ratio 91.2% vs 83.5%; Reinsurance $913M vs $650M; float $177.5B; insurance and other cash and Treasury Bills net $359.2B; consolidated cash $35,096M + $324,905M + $5,513M; equity securities $323.8B; H1 purchases of equities $39.4B and sales $27.8B; acquisitions of businesses net of cash $9.7B; $4.8B of treasury stock acquired in H1, most in Q2; OxyChem about $9.4B on 2 January; Taylor Morrison agreed 31 May at $72.50 a share, about $6.8B, closed 24 July; notes payable of insurance and other $43.3B; shareholders' equity $747.9B; BNSF revenue $6,601M vs $5,769M, fuel $1,173M vs $698M; BHE revenue $6,735M vs $6,418M; investment income down 9.1% on lower interest rates — Q2 2026 · publ. August 2026 · source ↗
  3. Moat Explorer calcAbout $365 billion in cash and Treasury bills at the end of June 2026 is, on the surface, a drag — money earning a modest yield while everyone waits.
    Moat Explorer calculation from Berkshire's Forms 10-K FY2016-FY2025 and 10-Qs for Q1 and Q2 2026: operating earnings = net earnings less after-tax investment gains and the 2025 impairments (FY2023 $37,350M, FY2024 $47,437M, FY2025 $44,486M; Q2 2026 $12,983M vs $11,160M; H1 2026 $24,329M vs $20,801M); consolidated cash and Treasury Bills $397.4B (31 March 2026) and $365.5B (30 June 2026); underwriting as a share of float; OxyChem at 2.6% of the cash pile; five-line after-tax earnings sums — 2016 to Q2 2026 · publ. 2026-09-23 · source ↗
  4. ReportedAnd the reported figures understate it: GAAP earnings swing wildly with the mark-to-market of the stock portfolio, so the placid, growing stream of operating earnings — $44.5 billion in 2025 — is the truer measure, obscured by accounting noise the market half-remembers to look through.
    Accounting standard ASU 2016-01 (effective 2018) — unrealized equity gains/losses flow through net income, making Berkshire's GAAP earnings swing with its stock portfolio — Since 2018 · publ. 2018 · source ↗
  5. Moat Explorer calcAnd the reported figures understate it: GAAP earnings swing wildly with the mark-to-market of the stock portfolio, so the placid, growing stream of operating earnings — $44.5 billion in 2025 — is the truer measure, obscured by accounting noise the market half-remembers to look through.
    Moat Explorer calculation from Berkshire's Forms 10-K FY2016-FY2025 and 10-Qs for Q1 and Q2 2026: operating earnings = net earnings less after-tax investment gains and the 2025 impairments (FY2023 $37,350M, FY2024 $47,437M, FY2025 $44,486M; Q2 2026 $12,983M vs $11,160M; H1 2026 $24,329M vs $20,801M); consolidated cash and Treasury Bills $397.4B (31 March 2026) and $365.5B (30 June 2026); underwriting as a share of float; OxyChem at 2.6% of the cash pile; five-line after-tax earnings sums — 2016 to Q2 2026 · publ. 2026-09-23 · source ↗
  6. ReportedGreg Abel took the reins with the balance sheet at its strongest, resumed the buybacks Buffett had paused — $4.8 billion in the first half of 2026 — and signaled unbroken discipline.
    Berkshire Hathaway Form 10-Q, quarter ended 30 June 2026 - after-tax earnings (underwriting $1,731M vs $1,992M, insurance investment income $3,059M vs $3,367M, BNSF $1,558M vs $1,466M, BHE $891M vs $702M, manufacturing, service and retailing $4,470M vs $3,601M, investment gains $12,684M, net earnings $25,667M); GEICO pre-tax underwriting $994M vs $1,821M, combined ratio 91.2% vs 83.5%; Reinsurance $913M vs $650M; float $177.5B; insurance and other cash and Treasury Bills net $359.2B; consolidated cash $35,096M + $324,905M + $5,513M; equity securities $323.8B; H1 purchases of equities $39.4B and sales $27.8B; acquisitions of businesses net of cash $9.7B; $4.8B of treasury stock acquired in H1, most in Q2; OxyChem about $9.4B on 2 January; Taylor Morrison agreed 31 May at $72.50 a share, about $6.8B, closed 24 July; notes payable of insurance and other $43.3B; shareholders' equity $747.9B; BNSF revenue $6,601M vs $5,769M, fuel $1,173M vs $698M; BHE revenue $6,735M vs $6,418M; investment income down 9.1% on lower interest rates — Q2 2026 · publ. August 2026 · source ↗
Sources
Generated September 23, 2026